PortfoliosLab logo
UFPT vs. ABBV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between UFPT and ABBV is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

UFPT vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in UFP Technologies, Inc. (UFPT) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

UFPT:

-0.06

ABBV:

0.57

Sortino Ratio

UFPT:

0.28

ABBV:

0.96

Omega Ratio

UFPT:

1.03

ABBV:

1.15

Calmar Ratio

UFPT:

-0.07

ABBV:

0.87

Martin Ratio

UFPT:

-0.15

ABBV:

2.07

Ulcer Index

UFPT:

24.34%

ABBV:

8.72%

Daily Std Dev

UFPT:

52.73%

ABBV:

28.31%

Max Drawdown

UFPT:

-88.53%

ABBV:

-45.09%

Current Drawdown

UFPT:

-29.33%

ABBV:

-14.28%

Fundamentals

Market Cap

UFPT:

$1.95B

ABBV:

$325.05B

EPS

UFPT:

$8.46

ABBV:

$2.37

PE Ratio

UFPT:

29.94

ABBV:

77.65

PEG Ratio

UFPT:

0.00

ABBV:

0.39

PS Ratio

UFPT:

3.57

ABBV:

5.67

PB Ratio

UFPT:

5.21

ABBV:

228.91

Total Revenue (TTM)

UFPT:

$547.56M

ABBV:

$57.37B

Gross Profit (TTM)

UFPT:

$158.76M

ABBV:

$44.44B

EBITDA (TTM)

UFPT:

$101.14M

ABBV:

$16.33B

Returns By Period

In the year-to-date period, UFPT achieves a 3.59% return, which is significantly lower than ABBV's 5.50% return. Over the past 10 years, UFPT has outperformed ABBV with an annualized return of 29.02%, while ABBV has yielded a comparatively lower 15.58% annualized return.


UFPT

YTD

3.59%

1M

20.01%

6M

-14.12%

1Y

-2.48%

5Y*

42.18%

10Y*

29.02%

ABBV

YTD

5.50%

1M

6.38%

6M

13.63%

1Y

14.60%

5Y*

19.88%

10Y*

15.58%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

UFPT vs. ABBV — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UFPT
The Risk-Adjusted Performance Rank of UFPT is 4646
Overall Rank
The Sharpe Ratio Rank of UFPT is 4848
Sharpe Ratio Rank
The Sortino Ratio Rank of UFPT is 4444
Sortino Ratio Rank
The Omega Ratio Rank of UFPT is 4343
Omega Ratio Rank
The Calmar Ratio Rank of UFPT is 4646
Calmar Ratio Rank
The Martin Ratio Rank of UFPT is 4747
Martin Ratio Rank

ABBV
The Risk-Adjusted Performance Rank of ABBV is 7171
Overall Rank
The Sharpe Ratio Rank of ABBV is 7373
Sharpe Ratio Rank
The Sortino Ratio Rank of ABBV is 6464
Sortino Ratio Rank
The Omega Ratio Rank of ABBV is 6767
Omega Ratio Rank
The Calmar Ratio Rank of ABBV is 8181
Calmar Ratio Rank
The Martin Ratio Rank of ABBV is 7373
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

UFPT vs. ABBV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for UFP Technologies, Inc. (UFPT) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current UFPT Sharpe Ratio is -0.06, which is lower than the ABBV Sharpe Ratio of 0.57. The chart below compares the historical Sharpe Ratios of UFPT and ABBV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

UFPT vs. ABBV - Dividend Comparison

UFPT has not paid dividends to shareholders, while ABBV's dividend yield for the trailing twelve months is around 3.47%.


TTM20242023202220212020201920182017201620152014
UFPT
UFP Technologies, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
ABBV
AbbVie Inc.
3.47%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%2.54%

Drawdowns

UFPT vs. ABBV - Drawdown Comparison

The maximum UFPT drawdown since its inception was -88.53%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for UFPT and ABBV. For additional features, visit the drawdowns tool.


Loading data...

Volatility

UFPT vs. ABBV - Volatility Comparison

UFP Technologies, Inc. (UFPT) has a higher volatility of 15.05% compared to AbbVie Inc. (ABBV) at 11.11%. This indicates that UFPT's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

UFPT vs. ABBV - Financials Comparison

This section allows you to compare key financial metrics between UFP Technologies, Inc. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20212022202320242025
148.15M
13.34B
(UFPT) Total Revenue
(ABBV) Total Revenue
Values in USD except per share items

UFPT vs. ABBV - Profitability Comparison

The chart below illustrates the profitability comparison between UFP Technologies, Inc. and AbbVie Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%80.0%20212022202320242025
28.5%
83.9%
(UFPT) Gross Margin
(ABBV) Gross Margin
UFPT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, UFP Technologies, Inc. reported a gross profit of 42.15M and revenue of 148.15M. Therefore, the gross margin over that period was 28.5%.

ABBV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a gross profit of 11.20B and revenue of 13.34B. Therefore, the gross margin over that period was 83.9%.

UFPT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, UFP Technologies, Inc. reported an operating income of 23.13M and revenue of 148.15M, resulting in an operating margin of 15.6%.

ABBV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported an operating income of 3.73B and revenue of 13.34B, resulting in an operating margin of 28.0%.

UFPT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, UFP Technologies, Inc. reported a net income of 17.18M and revenue of 148.15M, resulting in a net margin of 11.6%.

ABBV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a net income of 1.29B and revenue of 13.34B, resulting in a net margin of 9.6%.